Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.102954Source: DataRank Database

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2 is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.87)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Peter C. Fridy ORCID,Natalia E. Ketaren ORCID,Fred D. Mast ORCID,Song Li ORCID,Jean Paul Olivier ORCID

Live enrichment

PubMed:36720309 PMC:PMC9884143 OpenAlex:https://openalex.org/W4318384412

National Institutes of Health

Grant: P41 GM109824

Rockefeller University

Grant: SCR_020986

NIAID NIH HHS

Grant: R01 AI189657

National Institutes of Health

Grant: 3P41GM109824-09S1

Equipment supplement for NCDIR

FWCI

3.87

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.jbc.org/article/S0021925823000868/pdf

publisherhttp://www.jbc.org/article/S0021925823000868/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925823000868?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925823000868?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jbc.2023.102954

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCell Image Analysis TechniquesTransgenic Plants and Applications0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingAntibodies, ViralComplementarity Determining RegionsSaccharomyces cerevisiaeSARS-CoV-2Single-Domain AntibodiesSpike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

SARS-CoV-2AnimalsAntibodies, ViralSaccharomyces cerevisiaeComplementarity Determining RegionsAntibodies, NeutralizingSingle-Domain AntibodiesSpike Glycoprotein, Coronavirus

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)YeastVirologySars virusCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBiologyChemistryMolecular biologyComputational biologyGeneticsMedicineMonoclonal antibodiesDNA shufflingYeast displayNanobodiesEpitope BinningCovid-19Sars-cov-2Spike Glycoprotein, CoronavirusAnimalsSaccharomyces cerevisiaeSingle-Domain AntibodiesAntibodies, ViralAntibodies, NeutralizingComplementarity Determining RegionsResearch Article

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure